Interpreting risk across lean MASLD phenotypes

Journal of Gastroenterology · Published 2026-07-30 · DOI 10.1007/s00535-026-02494-2

Authors (3)

Bin Wei, Huanhuan Li, Xiaorong Wu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wei, B., Li, H., Wu, X. (2026). Interpreting risk across lean MASLD phenotypes. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02494-2

Related articles

• Clinical outcomes of lean metabolic dysfunction-associated steatotic liver disease by phenotypic subtypes · Journal of Gastroenterology · 2026 · Cites or is cited by this article · Same journal
• Clinical characteristics of acute pancreatitis in patients with inflammatory bowel disease: a nationwide survey in Japan · Journal of Gastroenterology · 2026 · Same journal
• Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nationwide multicenter study · Journal of Gastroenterology · 2026 · Same journal
• Diagnostic performance of magnifying endoscopy with third-generation narrow-band imaging for early gastric cancer: post hoc analysis of a randomized trial (3G detection trial) · Journal of Gastroenterology · 2026 · Same journal
• Comment on “Intestinal obstruction impairs the antitumor function of hepatic natural killer cells against colorectal cancer” · Journal of Gastroenterology · 2026 · Same journal
• Clinical applications of gut microbiome for non-invasive diagnosis of colorectal neoplasia · Journal of Gastroenterology · 2026 · Same journal
• Dependence-related screening positivity among regular stimulant-laxative users with chronic constipation: a multicenter prospective observational study · Journal of Gastroenterology · 2026 · Same journal
• A modified Delphi consensus on fusion (laparoscopic and robotic) approaches to colorectal surgery in Asia–Pacific · Journal of Gastroenterology · 2026 · Same journal
• HOXC9 enhances cholesterol metabolism and malignancy in pancreatic ductal adenocarcinoma through ITGA10/FAK/PI3K/CREB-dependent HMGCR activation · Journal of Gastroenterology · 2026 · Same journal
• Vonoprazan is associated with a phenotype-specific increase in cholangitis reporting in immune checkpoint inhibitor-treated patients: a VigiBase pharmacovigilance study · Journal of Gastroenterology · 2026 · Same journal